|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, April 20, 2017 ) Rising diabetic population and advancements in insulin delivery technologies are the factors fueling the market. Also, increasing adoption of smartphones which has made treatment easy is other major factor fueling the market. However, high cost of pens compared to injections and availability of alternative treatments may hamper the market growth. North America accounted for the largest share followed by Europe owing to growing aging population, increased funding for patients by health insurance companies and technological advancements.
For more information about this report: http://www.reportsweb.com/smart-insulin-pens-global-market-outlook-2016-2022
Some of the key players in Global Smart Insulin Pens market include Vigihealth, Novo Nordisk A/S, Eli Lilly And Company, Jiangsu Delfu Medical Device Co.,Ltd, Emperra Gmbh and Digital Medics Ptd Ltd.
Fabrication Material Covered:
- Plastic
- Metal
Technologies Covered:
- Jet Injectors
- Bluetooth
- Spring Loaded
End Users Covered:
- Retail Pharmacies
- E-commerce
- Hospital Pharmacies
- Drugstores
Products Covered:
- Accessories
o Pen Needles
o Timesulin Pen Cap
o Insulin Cartridge
- Prefilled/ Disposable Insulin Pens
- Reusable/ Durable Insulin Pens
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001564943/sample
Regions Covered:
- North America
o US
o Canada
o Mexico
- Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
- Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
- Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Company Profiling
11.1 Vigihealth
11.2 Novo Nordisk A/S
11.3 Eli Lilly And Company
11.4 Jiangsu Delfu Medical Device Co.,Ltd
11.5 Emperra Gmbh
11.6 Digital Medics Ptd Ltd
Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001564943/buying
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
